Growth Metrics

Tandem Diabetes Care (TNDM) Shares Repurchased (2024)

Tandem Diabetes Care posted quarterly Shares Repurchased of $30.0 million for Q1 2024.

Tandem Diabetes Care (TNDM) has 1 years of Shares Repurchased data on file, last reported at $30.0 million in Q1 2024.

  • For the quarter ending Q1 2024, Shares Repurchased changed N/A year-over-year to $30.0 million; the trailing twelve-month figure through Dec 2024 stood at $30.0 million (changed N/A YoY), and the FY2024 full-year result was $30.0 million, changed N/A from the prior year.
  • Shares Repurchased for Q1 2024 stood at $30.0 million.
  • Across five years, Shares Repurchased topped out at $30.0 million in Q1 2024 and bottomed at $30.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 180.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 105.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 421.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 100.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 30.00 Mn
Mar 31, 2024 30.00 Mn